Differential cytokine secretion of cultured bone marrow stromal cells from patients with psoriasis and healthy volunteers

European Journal of Dermatology

Volumn 20, Issue 1, 2010, Pages 49-53

  Zhang, Kaiming ^a   Liu, Ruifeng ^a   Yin, Guohua ^a   Li, Xinhua ^a   Li, Junqin ^a   Zhang, Jing ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow stromal cells; Cytokines profile; Psoriasis; Secretion

Indexed keywords

BETA1 INTEGRIN; CD34 ANTIGEN; CD45 ANTIGEN; CYTOKINE; EPIDERMAL GROWTH FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 11; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADOLESCENT; ADULT; ARTICLE; BONE MARROW; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MALE; MICROENVIRONMENT; PROTEIN EXPRESSION; PSORIASIS; SKIN BIOPSY; STROMA CELL;

ADOLESCENT; ADULT; ANTIGENS, CD; BONE MARROW CELLS; CELLS, CULTURED; CYTOKINES; DOBUTAMINE; FEMALE; FLOW CYTOMETRY; HEMATOPOIESIS; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; PSORIASIS; STROMAL CELLS; YOUNG ADULT;

EID: 76749096707     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.0845     Document Type: Article

References (38)

1. Zhang K, Zhang R, Li X, et al. The mRNA expression and promoter methylation status of the p16 gene in colony-forming cells with high proliferative potential in patients with psoriasis. Clin Exp Dermatol 2007; 32: 702-8.
2. Bowcock AM. Understanding the pathogenesis of psoriasis, psoriatic arthritis, and autoimmunity via a fusion of molecular genetics and immunology. Immunol Res 2005; 32: 45-56.
3. Perez-Lorenzo R, Zambrano-Zaragoza JF, Saul A, et al. Autoantibodies to autologous skin in guttate and plaque forms of psoriasis and cross-reaction of skin antigens with streptococcal antigens. Int J Dermatol 1998; 37: 524-31.
4. Ockenfels HM. Trigger factors for psoriasis. Hautarzt 2003; 54: 215-23.
5. Ferran M, Giménez-Arnau AM, Bellosillo B, et al. Effector function of CLA(+) T lymphocytes on autologous keratinocytes in psoriasis. Actas Dermosifiliogr 2008; 99: 701-7.
6. +T lymphocytes on C-myc, Bcl-xL and Ki67 gene expression in keratinocytes. Eur J Dermatol 2007; 17: 392-6.
7. International Psoriasis Genetics Consortium. The International Psoriasis Genetics Study: assessing linkage to 14 candidate susceptibility loci in a cohort of 942 affected sib pairs. Am J Hum Genet 2003; 73: 430-7.
8. Rahman P, Elder JT. Genetic epidemiology of psoriasis and psoriatic arthritis. Ann Rheum Dis 2005; 64 (Suppl. 2): 7-9.
9. Li B, Berman J, Tang JT, et al. The early growth response factor-1 is involved in stem cell factor (SCF)-induced interleukin 13 production by mast cells, but is dispensable for SCF-dependent mast cell growth. J Biol Chem 2007; 282: 22573-81.
10. Ma HL, Liang S, Li J, et al. IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation. J Clin Invest 2008; 118: 597-607.
11. Zarrabeitia MT, Farinas MC, Rodriguez-Valverde V, et al. T and B cell function in psoriasis and psoriatic arthropathy. Allergol Immunopathol (Madr) 1989; 17: 155-9.
12. Schon M, Denzer D, Kubitza RC, et al. Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice. J Invest Dermatol 2000; 114: 976-83.
13. Rocha-Pereira P, Santos-Silva A, Rebelo I, et al. Erythrocyte damage in mild and severe psoriasis. Br J Dermatol 2004; 150: 232-44.
14. + regulatory T cells differentiated in vitro from bone marrow-derived haematopoietic cells of psoriatic patients with a family history of the disorder. Br J Dermatol 2008; 158: 298-305.
15. Zhang K, Zhang R, Li X, et al. Promoter methylation status of p15 and p21 genes in HPP-CFCs of bone marrow of patients with psoriasis. Eur J Dermatol 2009; 19: 141-6.
16. Snowden JA, Heaton DC. Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. Br J Dermatol 1997; 137: 130-2.
17. Eedy DJ, Burrows D, Bridges JM, et al. Clearance of severe psoriasis after allogenic bone marrow transplantation. BMJ 1990; 300: 908.
18. Reilly DM, Parslew R, Sharpe GR, et al. Inflammatory mediators in normal, sensitive and diseased skin types. Acta Derm Venereol 2000; 80: 171-4.
19. Boroujeni MB, Salehnia M, Valojerdi MR, et al. Comparison of gene expression profiles in erythroid-like cells derived from mouse embryonic stem cells differentiated in simple and co-culture systems. Am J Hematol 2008; 83: 109-15.
20. Arnold R, Seifert M, Asadullah K, et al. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines. J Immunol 1999; 162: 7140-7.
21. Sun LY, Zhang HY, Feng XB, et al. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 2007; 16: 121-8.
22. Sabat R, Philipp S, Höflich C, et al. Immunopathogenesis of psoriasis. Exp Dermatol 2007; 16: 779-98.
23. Niitsu N, Khori M, Hayama M, et al. Phase I/II study of the rituximab-EPOCT regimen in combination with granulocyte colony-stimulating factor in patients with relapsed or refractory follicular lymphoma including evaluation of its cardiotoxicity using B-type natriuretic peptide and troponin T levels. Clin Cancer Res 2005; 11 (2 Pt 1): 697-702.
24. Kafka D, Ling E, Feldman G, et al. Contribution of IL-1 to resistance to Streptococcus pneumoniae infection. Int Immunol 2008; 20: 1139-46.
25. Debets R, Hegmans JP, Croughs P, et al. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol 1997; 158: 2955-63.
26. Cooper KD, Hammerberg C, Baadsgaard O, et al. Interleukin-1 in human skin: dysregulation in psoriasis. J Invest Dermatol 1990; 95: 24S-26S.
27. Cooper KD, Hammerberg C, Baadsgaard O, et al. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. J Immunol 1990; 144: 4593-603.
28. Takematsu H, Ohmoto Y, Tagami H. Decreased levels of IL-1 alpha and beta in psoriatic lesional skin. Tohoku J Exp Med 1990; 161: 159-69.
29. Huang B, Lei Z, Zhang GM, et al. SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 2008; 112: 1269-79.
30. Sa SM, Valdez PA, Wu J, et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 2007; 178: 2229-40.
31. Takano H, Qin Y, Hasegawa H, et al. Effects of G-CSF on left ventricular remodeling and heart failure after acute myocardial infarction. J Mol Med 2006; 84: 185-93.
32. Takano H, Ohtsuka M, Akazawa H, et al. Pleiotropic effects of cytokines on acute myocardial infarction: G-CSF as a novel therapy for acute myocardial infarction. Curr Pharm Des 2003; 9: 1121-7.
33. Hara T, Ichihara M, Takagi M, et al. Interleukin-3 (IL-3) poorresponsive inbred mouse strains carry the identical deletion of a branch point in the IL-3 receptor alpha subunit gene. Blood 1995; 85: 2331-6.
34. Peters SO, Kittler EL, Ramshaw HS, et al. Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 1996; 87: 30-7.
35. Toth ZE, Leker RR, Shahar T, et al. The combination of granulocyte colony-stimulating factor and stem cell factor significantly increases the number of bone marrow-derived endothelial cells in brains of mice following cerebral ischemia. Blood 2008; 111: 5544-52.
36. Smith MA, Court EL, Smith JG. Stem cell factor: laboratory and clinical aspects. Blood Rev 2001; 15: 191-7.
37. Xu M, Uemura R, Dai Y, et al. In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J Mol Cell Cardiol 2007; 42: 441-8.
38. Woods AC, Mant MJ. Amelioration of severe psoriasis with psoriatic arthritis for 20 years after allogeneic haematopoietic stem cell transplantation. Ann Rheum Dis 2006; 65: 697.